HAYWARD, CA – January 11, 2017 – Mawi DNA Technologies, a biotechnology company focusing on development of innovative technologies for biosampling, announces the launch of iSWAB-Microbiome (ISWAB-MB) designed to collect and stabilize microbial content and diversity within collected gut, rectal, vaginal, skin, oral or soil samples from collection to processing.
“iSWAB-MB significantly improves on current sampling and transport methods such as freezing or organic solvents. These collection methods can be challenging to use in the field and often result in alterations to the microbiome from time of collection to processing,” said Dr. Bassam El-Fahmawi, President and CTO of Mawi DNA Technologies. He added that offering an accurate snapshot of the microbiome representation at the exact time of collection is critical for a more precise understanding of the relationship between microbiome diversity and human or animal health.
The ISWAB-MB was developed to overcome issues that can affect microbiome research by:
“This product would be an ideal match for a project like the National Microbiome Initiative launched in May 2016,” said Jerome David, Vice President at Mawi DNA Technologies. “Our goal is to aggressively pursue these opportunities in 2017 and beyond.”
Samples of the iSWAB-MB product can be requested at www.mawidna.com
Candida Data Using iSWAB In Response to New Infectious Diseases...
A deadly fungal infection, Candida Auris, is becoming a serious threat. This drug-resistant strain is deadly for those with weakened immune systems and is spreading at an alarming rate. The READ MORE
Top Reasons to Ditch Your Current VTM. Upgrade your Viral…...
Mawi DNA has developed iSWAB-RC-EL, an FDA approved sample collection device for transport and storage of samples suspected of containing an infectious disease*. Why iSWAB-RC-EL is the superior op...READ MORE
Mawi DNA Announces Dr. Bouzyk as New Board Member!...
It is with great delight and excitement that we announce that Dr. READ MORE